STAIR XI
Stroke Treatment Academic Industry Roundtable
October 1-2, 2020
CYBER STAIR XI
STAIR XI was rescheduled from its original date of March 23-24, 2020 and was convened on October 1-2, 2020 as a virtual conference entitled CYBER STAIR XI.
STAIR XI was one of the most important STAIR conferences to date because recent stroke clinical trials have dramatically altered the landscape in our understanding of the stroke treatment time window. This new "transparent time window" significantly impacts study design, objectives and outcomes determination as well as cross-industry device and drug company collaborations including imaging integration.
STAIR XI leads in developing new strategies incorporating these breakthroughs. This new frontier raises important questions, poses unique challenges and presents new opportunities to the stroke research, development and treatment communities which STAIR XI addressed.
CYBER STAIR XI
- The Transparent Time Window -
New Perspectives in Reperfusion, Neuroprotection and Imaging
STAIR Day One
The five main conference sessions with over 20 presentations will address the following critical concerns:
-
Acute Stroke Trials: New Data, New Landscape, New Designs
-
Neuroprotection: Preclinical and Clinical Evaluation in 2020
-
Role of Imaging in Recent and Future Clinical Trials
-
Intravenous Thrombolysis Trial Design plus NINDS - STEP Platform
-
Regulatory Perspectives on Clinical Trial Issues:
-
Image-based Subject Selection
-
Drug, Device and Combined Study Regulations and Policies
STAIR Day Two
Consensus Workshops to Develop Recommendations
Consensus Workshop 1:
Top Priorities for Neuroprotective Studies
Facilitators – Chair: Pat Lyden Co-chair: Eng Lo
Consensus Workshop 2:
Imaging Workshop - The Time Window Gets Transparent
Facilitators – Chair: Bruce Campbell Co-chair: Maarten Lansberg
Consensus Workshop 3:
How to Establish the "Outer Limits" of Reperfusion Therapies
Facilitators – Chair: Larry Wechsler Co-chair: Tudor Jovin
True to the STAIR model, via a facilitated consensus process, participants developed recommendations covering the most compelling and timely questions facing the field today. The final manuscripts containing these consensus statements have been published in the journal Stroke. Participants who contributed to these publications are listed therein.
